120 related articles for article (PubMed ID: 38599643)
21. Predictive value of systemic immune-inflammation index for pathological complete response in patients receiving neoadjuvant immunochemotherapy for locally advanced esophageal cancer.
Han W; Weng K; Zhang P; Hong Z
Front Surg; 2022; 9():1091601. PubMed ID: 36684142
[TBL] [Abstract][Full Text] [Related]
22. Multifocal regression and pathologic response predicts recurrence after neoadjuvant chemotherapy in head and neck squamous cell carcinoma.
Kiong KL; Bell D; Yao CM; Ferrarotto R; Lewis CM
Oral Oncol; 2021 Nov; 122():105520. PubMed ID: 34521029
[TBL] [Abstract][Full Text] [Related]
23. [Multicenter real-world study on safety and efficacy of neoadjuvant therapy in combination with immunotherapy for colorectal cancer].
Liu XZ; Xiong Z; Xiao BY; Yu GY; Li YJ; Yao YF; Tao KX; Ding PR; Zhang W; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):219-227. PubMed ID: 35340171
[No Abstract] [Full Text] [Related]
24. Comprehensive
Cui Y; Lin Y; Zhao Z; Long H; Zheng L; Lin X
Front Immunol; 2022; 13():994917. PubMed ID: 36466929
[TBL] [Abstract][Full Text] [Related]
25. CT radiomics nomogram for prediction of the Ki-67 index in head and neck squamous cell carcinoma.
Zheng YM; Chen J; Zhang M; Wu ZJ; Tang GZ; Zhang Y; Dong C
Eur Radiol; 2023 Mar; 33(3):2160-2170. PubMed ID: 36222864
[TBL] [Abstract][Full Text] [Related]
26. A novel nomogram and risk classification system for predicting overall survival in head and neck squamous cell cancer with distant metastasis at initial diagnosis.
Zhu RQ; Zhang YM; Luo XY; Shen WY; Zhu HY
Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1467-1478. PubMed ID: 36316576
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: a real-world retrospective study.
Wu WJ; Liu Q; An PG; Wang L; Zhang JY; Chen Y; Zhang T; Zhang J
Front Immunol; 2023; 14():1282629. PubMed ID: 38035079
[TBL] [Abstract][Full Text] [Related]
28. An integrated nomogram combining lncRNAs classifier and clinicopathologic factors to predict the recurrence of head and neck squamous cell carcinoma.
Cui J; Wen Q; Tan X; Piao J; Zhang Q; Wang Q; He L; Wang Y; Chen Z; Liu G
Sci Rep; 2019 Nov; 9(1):17460. PubMed ID: 31767907
[TBL] [Abstract][Full Text] [Related]
29. Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort.
Issa M; Klamer BG; Mladkova N; Laliotis GI; Karivedu V; Bhateja P; Byington C; Dibs K; Pan X; Chakravarti A; Grecula J; Jhawar SR; Mitchell D; Baliga S; Old M; Carrau RL; Rocco JW; Blakaj DM; Bonomi M
BMC Cancer; 2022 Jul; 22(1):767. PubMed ID: 35836204
[TBL] [Abstract][Full Text] [Related]
30. Treatment patterns and clinical outcomes of patients with resectable non-small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World).
Yang Z; Wang S; Yang H; Jiang Y; Zhu L; Zheng B; Fu H; Ma J; Xie H; Wang Z; He H; Xia C; Li R; Xu J; Han J; Huang X; Li Y; Zhao B; Ni C; Xing H; Chen Y; Wang J; Jiang Y; Song Y; Mao Y; Chen C; Yao F; Zhang G; Hu J; Xue Q; Gao S; He J;
J Thorac Cardiovasc Surg; 2024 Feb; ():. PubMed ID: 38342430
[TBL] [Abstract][Full Text] [Related]
31. A clinical nomogram for predicting tumor regression grade in esophageal squamous-cell carcinoma treated with immune neoadjuvant immunotherapy.
Yu Y; Wang W; Qin Z; Li H; Liu Q; Ma H; Sun H; Bauer TL; Pimiento JM; Gabriel E; Birdas T; Li Y; Xing W
Ann Transl Med; 2022 Jan; 10(2):102. PubMed ID: 35282099
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma.
Vos JL; Elbers JBW; Krijgsman O; Traets JJH; Qiao X; van der Leun AM; Lubeck Y; Seignette IM; Smit LA; Willems SM; van den Brekel MWM; Dirven R; Baris Karakullukcu M; Karssemakers L; Klop WMC; Lohuis PJFM; Schreuder WH; Smeele LE; van der Velden LA; Bing Tan I; Onderwater S; Jasperse B; Vogel WV; Al-Mamgani A; Keijser A; van der Noort V; Broeks A; Hooijberg E; Peeper DS; Schumacher TN; Blank CU; de Boer JP; Haanen JBAG; Zuur CL
Nat Commun; 2021 Dec; 12(1):7348. PubMed ID: 34937871
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant PD-1/PD-L1 axis blockade for patients with head and neck squamous cell carcinoma.
Huang S; Xiong C; Tan K
Am J Otolaryngol; 2023; 44(6):103985. PubMed ID: 37442083
[TBL] [Abstract][Full Text] [Related]
34. [Construction of a nomogram prediction model for pathological complete response (pCR) of ipsilateral supraclavicular lymph node after neoadjuvant chemotherapy for breast cancer with first diagnosis of ipsilateral supraclavicular lymph node metastasis].
Lyu MH; Jiao DC; Wu JZ; Tian PQ; Ma YZ; Liu ZZ; Chen XC
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):160-166. PubMed ID: 35184460
[No Abstract] [Full Text] [Related]
35. Development of a nomogram for the prediction of pathological complete response after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.
Chao YK; Chang HK; Tseng CK; Liu YH; Wen YW
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27868287
[TBL] [Abstract][Full Text] [Related]
36. Pathological response and prognostic factors of neoadjuvant PD-1 blockade combined with chemotherapy in resectable oesophageal squamous cell carcinoma.
Wang H; Jiang Z; Wang Q; Wu T; Guo F; Xu Z; Yang W; Yang S; Feng S; Wang X; Chen S; Cheng C; Chen W
Eur J Cancer; 2023 Jun; 186():196-210. PubMed ID: 37045666
[TBL] [Abstract][Full Text] [Related]
37. Preoperative immunochemotherapy for locally advanced non-small cell lung cancer: an analysis of the clinical outcomes, optimal number of cycles, and peripheral immune markers.
Deng H; Liang H; Chen J; Wang W; Li J; Xiong S; Cheng B; Li C; Chen Z; Wang H; Zheng J; Guo Z; He J; Liang W
Transl Lung Cancer Res; 2022 Dec; 11(12):2364-2381. PubMed ID: 36636407
[TBL] [Abstract][Full Text] [Related]
38. Peripheral T lymphocyte and immunocyte subset dynamics: markers of neoadjuvant therapy outcomes in esophageal squamous cell carcinoma.
Nie X; He S; Nie X; Li C; Du K; He W; Li Z; Ni K; Lu S; Wang C; Wang K; Miao Y; Jiang L; Lv J; Liu G; Fang Q; Peng L; Xiao W; Wang Q; Wang D; Han Y; Leng X
Front Immunol; 2023; 14():1320282. PubMed ID: 38179053
[TBL] [Abstract][Full Text] [Related]
39. Dynamic alteration in SULmax predicts early pathological tumor response and short-term prognosis in non-small cell lung cancer treated with neoadjuvant immunochemotherapy.
Sun T; Huang S; Jiang Y; Yuan H; Wu J; Liu C; Zhang X; Tang Y; Ben X; Tang J; Zhou H; Zhang D; Xie L; Chen G; Zhao Y; Wang S; Xu H; Qiao G
Front Bioeng Biotechnol; 2022; 10():1010672. PubMed ID: 36277407
[No Abstract] [Full Text] [Related]
40. Radiomics from dual-energy CT-derived iodine maps predict lymph node metastasis in head and neck squamous cell carcinoma.
Zhang W; Liu J; Jin W; Li R; Xie X; Zhao W; Xia S; Han D
Radiol Med; 2024 Feb; 129(2):252-267. PubMed ID: 38015363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
